We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$80.3M
AUM Growth
+$6.68M
Cap. Flow
-$15.7M
Cap. Flow %
-19.56%
Top 10 Hldgs %
78.33%
Holding
71
New
23
Increased
2
Reduced
8
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Communication Services 15.54%
3 Energy 6.49%
4 Technology 5.56%
5 Consumer Staples 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMWP
1
DELISTED
Eros Media World PLC
EMWP
$12.5M 15.54%
48,012
+7,161
+18% +$1.76M
NVAX icon
2
Novavax
NVAX
$1.21B
$4.44M 5.53%
+165,780
New +$5.6M
VERI icon
3
Veritone
VERI
$92.9M
$4.4M 5.47%
+261,422
New +$5.09M
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$4.17M 5.19%
+54,197
New +$4.36M
TELL
5
DELISTED
Tellurian Inc.
TELL
$3.78M 4.71%
+454,294
New +$4.54M
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$2.57M 3.2%
+44,679
New +$4.12M
MRKR icon
7
Marker Therapeutics
MRKR
$18.5M
$2.36M 2.94%
+25,000
New +$1.27M
WHWK
8
Whitehawk Therapeutics
WHWK
$181M
$1.87M 2.33%
+30,045
New +$1.82M
KURA icon
9
Kura Oncology
KURA
$793M
$1.39M 1.73%
+76,200
New +$1.29M
NOVN
10
DELISTED
Novan, Inc. Common Stock
NOVN
$1.19M 1.48%
40,513
-5,467
-12% -$165K
FURY
11
Fury Gold Mines
FURY
$101M
$1.07M 1.33%
660,575
-98,637
-13% -$185K
RKDA icon
12
Arcadia Biosciences
RKDA
$1.42M
$984K 1.22%
+2,986
New +$1.63M
PFIE
13
DELISTED
Profire Energy, Inc
PFIE
$939K 1.17%
+277,721
New +$1.12M
CVM icon
14
CEL-SCI Corp
CVM
$19.9M
$737K 0.92%
+26,700
New +$1.97M
NUWE icon
15
Nuwellis
NUWE
$174K
0
LMNR icon
16
Limoneira
LMNR
$244M
$639K 0.8%
+25,946
New +$632K
BNBX
17
DELISTED
BNB PLUS CORP
BNBX
$623K 0.78%
1
RCON icon
18
Recon Technology
RCON
$32.2M
$493K 0.61%
3,940
-4,168
-51% -$500K
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
$480K 0.6%
+45,057
New +$439K
SMHI icon
20
SEACOR Marine Holdings
SMHI
$209M
$411K 0.51%
+17,809
New +$404K
SCYX icon
21
SCYNEXIS
SCYX
$37.4M
$388K 0.48%
2,957
-13,328
-82% -$1.59M
FCSC
22
DELISTED
Fibrocell Science Inc.
FCSC
$317K 0.39%
+117,099
New +$339K
NVIV
23
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$266K 0.33%
+209
New +$1.15M
CRDF icon
24
Cardiff Oncology
CRDF
$63M
$237K 0.3%
+51,241
New +$857K
GLMD icon
25
Galmed Pharmaceuticals
GLMD
$4.62M
$177K 0.22%
+83
New +$120K

Similar funds

CVI Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, CVI Holdings held 71 positions worth $80.3M, up 9.1% from $73.7M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $15.7M in Q2 2018, closing 18 positions and reducing 8 holdings. Its most notable exit was Agree Realty, an estimated $5.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.

Against the trend, CVI Holdings opened a new position in Novavax worth $4.44M.

  • CVI Holdings's largest Q2 2018 buy was Novavax: 165,780 shares worth $4.44M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2018, an estimated $1.76M increase.
  • CVI Holdings's biggest Q2 2018 reduction was SCYNEXIS, cutting an estimated $1.59M.
  • CVI Holdings fully exited Agree Realty in Q2 2018, selling an estimated $5.36M.
  • CVI Holdings's ten largest holdings make up 78% of its $80.3M portfolio in Q2 2018.
  • CVI Holdings opened 23 new positions and closed 18 in Q2 2018.
  • CVI Holdings's portfolio value rose 9.1% quarter-over-quarter to $80.3M.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.